Dochtor Kennedy As the President and Managing Attorney of AdvisorLaw, LLC, Dochtor Kennedy has always remained true to the company’s founding principles. AdvisorLaw provides a range of services to protect the integrity and clean up the besmirched reputation of FINRA licensed attorneys. Always trying to think from the client’s perspective, Doc Kennedy is able to figure out what is most needed for their case to succeed. Through his strategic direction, AdvisorLaw is able to provide dependable services in customer dispute expungement. This is while ensuring that any previous and resolved disputes no longer appear on the client’s U5 and BrokerCheck profiles as well as the CRD System. He also ensures that clients get the best assistance possible through Termination Disclosure Representation while ensuring that a U5/Employment Separation gets completely eliminated from the client’s CRD through an effective arbitration. Dedicating his efforts to helping clients gain back the reputation they have lost, Doctor Kennedy is able to formulate personalized plans of action for every client, ensuring that they get more than adequate, strong representation that can help them obtain a fresh foothold in their careers and in their lives. Doc Kennedy manages the breadth of Rule 2080 Customer Dispute expungement, along with U5 language modification, FINRA inquiry/investigation representation, FINRA OTR representation, and other services provided to advisors. He assigns a dedicated team that will work with the client from start to finish while ensuring that the client gets updated on every procedure and process so they are fully informed about the progress of their cases. Leaving no stone unturned, Dochtor Kennedy sees to it that the different working teams for their various clients have good access to resources and technology that can help them provide the best representation in the speedy and efficient resolution of cases. He provides advice and helps with solutions in order that clients know they are well taken care of right from the onset.